Matches in SemOpenAlex for { <https://semopenalex.org/work/W2972678222> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2972678222 endingPage "E380" @default.
- W2972678222 startingPage "E380" @default.
- W2972678222 abstract "Much of the progress in the definitive treatment of head and neck cancer (HNC) has come with combining radiation therapy (RT) and systemic therapy (ST). Yet RT-specific advances that draw upon radiobiologic principles (dose and fractionation) and technology (e.g. IMRT) have also led to improvements in HNC outcome. We aimed to characterize current HNC clinical trials, focusing on the role of RT to determine how often RT-specific hypotheses are tested. A web query of all open interventional trials on www.ClinicalTrials.gov was performed on 6/27/2017 using search terms “head and neck cancer” and specific HNC subsites. The details of each trial were characterized including the type of modality utilized (RT, drug, surgery, or other), principal investigator (PI) specialty, study funding, and whether the study tested a RT-modality specific hypothesis (focused on comparing RT dose, fractionation, techniques, use of any RT, or other). There were 841 open HNC trials identified including definitive (47.6%) and recurrent/metastatic (41.9%) populations. Most trials were phase I or non-randomized phase II studies (71.7%), rather than phase III or randomized phase II (28.3%). Among phase III and randomized phase II trials, most trials tested the combination of RT with ST (49.8%), while only 11.1% tested an RT-specific hypothesis such as dose, fractionation, modality (e.g. SBRT, protons, etc.), (p < 0.001). More trials tested an RT-specific hypothesis if one of the study PIs was a radiation oncologist (20.9% vs 6.0%, p < 0.001). Among RT-only trials, most early-phase studies tested novel treatment modalities (e.g. stereotactic radiation or proton therapy), while most later-phase studies tested dose and fractionation. RT-specific trials had low rates of federal (10.4%) or industry (2.6%) funding. RT modality-specific research hypotheses are a minority of phase II-III HNC trials, which mostly focus on incorporating ST in the definitive or recurrent/metastatic setting. Radiation oncologist PI leadership is likely to be an important factor in ensuring that radiobiologic, technologic, and other RT-specific hypotheses are incorporated into trial design to maximally exploit the potential for RT to improve HNC outcomes whether alone or in combination with ST." @default.
- W2972678222 created "2019-09-19" @default.
- W2972678222 creator A5024038350 @default.
- W2972678222 creator A5044221282 @default.
- W2972678222 creator A5055709149 @default.
- W2972678222 creator A5067347913 @default.
- W2972678222 creator A5073653003 @default.
- W2972678222 creator A5077566206 @default.
- W2972678222 creator A5087188178 @default.
- W2972678222 date "2019-09-01" @default.
- W2972678222 modified "2023-10-17" @default.
- W2972678222 title "Radiation Therapy in Head and Neck Cancer Clinical Research – Is there Room to Exploit Radiation-Specific Principles in Clinical Trial Design with or without Systemic Therapy?" @default.
- W2972678222 doi "https://doi.org/10.1016/j.ijrobp.2019.06.1639" @default.
- W2972678222 hasPublicationYear "2019" @default.
- W2972678222 type Work @default.
- W2972678222 sameAs 2972678222 @default.
- W2972678222 citedByCount "0" @default.
- W2972678222 crossrefType "journal-article" @default.
- W2972678222 hasAuthorship W2972678222A5024038350 @default.
- W2972678222 hasAuthorship W2972678222A5044221282 @default.
- W2972678222 hasAuthorship W2972678222A5055709149 @default.
- W2972678222 hasAuthorship W2972678222A5067347913 @default.
- W2972678222 hasAuthorship W2972678222A5073653003 @default.
- W2972678222 hasAuthorship W2972678222A5077566206 @default.
- W2972678222 hasAuthorship W2972678222A5087188178 @default.
- W2972678222 hasBestOaLocation W29726782221 @default.
- W2972678222 hasConcept C121608353 @default.
- W2972678222 hasConcept C126322002 @default.
- W2972678222 hasConcept C141071460 @default.
- W2972678222 hasConcept C143998085 @default.
- W2972678222 hasConcept C155806632 @default.
- W2972678222 hasConcept C168563851 @default.
- W2972678222 hasConcept C19527891 @default.
- W2972678222 hasConcept C2776530083 @default.
- W2972678222 hasConcept C2780920918 @default.
- W2972678222 hasConcept C2989005 @default.
- W2972678222 hasConcept C3018411727 @default.
- W2972678222 hasConcept C509974204 @default.
- W2972678222 hasConcept C535046627 @default.
- W2972678222 hasConcept C71924100 @default.
- W2972678222 hasConceptScore W2972678222C121608353 @default.
- W2972678222 hasConceptScore W2972678222C126322002 @default.
- W2972678222 hasConceptScore W2972678222C141071460 @default.
- W2972678222 hasConceptScore W2972678222C143998085 @default.
- W2972678222 hasConceptScore W2972678222C155806632 @default.
- W2972678222 hasConceptScore W2972678222C168563851 @default.
- W2972678222 hasConceptScore W2972678222C19527891 @default.
- W2972678222 hasConceptScore W2972678222C2776530083 @default.
- W2972678222 hasConceptScore W2972678222C2780920918 @default.
- W2972678222 hasConceptScore W2972678222C2989005 @default.
- W2972678222 hasConceptScore W2972678222C3018411727 @default.
- W2972678222 hasConceptScore W2972678222C509974204 @default.
- W2972678222 hasConceptScore W2972678222C535046627 @default.
- W2972678222 hasConceptScore W2972678222C71924100 @default.
- W2972678222 hasIssue "1" @default.
- W2972678222 hasLocation W29726782221 @default.
- W2972678222 hasOpenAccess W2972678222 @default.
- W2972678222 hasPrimaryLocation W29726782221 @default.
- W2972678222 hasRelatedWork W1526379664 @default.
- W2972678222 hasRelatedWork W1989116149 @default.
- W2972678222 hasRelatedWork W2039811832 @default.
- W2972678222 hasRelatedWork W2081124009 @default.
- W2972678222 hasRelatedWork W2108756183 @default.
- W2972678222 hasRelatedWork W2417837297 @default.
- W2972678222 hasRelatedWork W2473174439 @default.
- W2972678222 hasRelatedWork W2944218251 @default.
- W2972678222 hasRelatedWork W3129151516 @default.
- W2972678222 hasRelatedWork W2183937270 @default.
- W2972678222 hasVolume "105" @default.
- W2972678222 isParatext "false" @default.
- W2972678222 isRetracted "false" @default.
- W2972678222 magId "2972678222" @default.
- W2972678222 workType "article" @default.